Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.7.0.1
Consolidated Statements of Cash Flows
$ in Thousands
 12 Months Ended
Dec. 31, 2016
USD ($)
Jan. 02, 2016
USD ($)
Jan. 03, 2015
USD ($)
Operating activities      
Net loss including noncontrolling interests $ (603) $ (2,424) $ (7,086)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:      
Depreciation and amortization expense 7,510 7,510 8,923
Amortization of intangible assets 482 464 422
Deferred income taxes (838) (906) 74
Share-based compensation expense 3,131 2,419 2,371
Stock awards issued for non-employee director service 9 2 0
Impairment loss on intangible assets 1,130 0 0
Amortization of deferred financing costs 70 82 81
Gain from disposition of assets 0 (13) (96)
Changes in operating assets and liabilities:      
Accounts receivable (30) 568 1,105
Inventory 312 (2,854) (11,412)
Other current assets (255) 262 471
Other non-current assets 203 225 (39)
Accounts payable and accrued expenses 7,906 119 6,992
Other current liabilities 1,775 475 (302)
Other non-current liabilities 769 (184) (261)
Net cash provided by operating activities 21,571 5,745 1,243
Investing activities      
Additions to property and equipment (6,353) (7,780) (5,556)
Proceeds from sale of property and equipment 0 13 27
Cash paid for intangibles (125) (25) (200)
Proceeds from sale of marketable securities and investments 1 0 745
Purchases of marketable securities and investments 0 0 (746)
Net cash used in investing activities (6,477) (7,792) (5,730)
Financing activities      
Proceeds from revolving loan payable 13,727 15,637 19,506
Payments made on revolving loan payable (25,485) (14,900) (15,258)
Proceeds from sale of equity in subsidiary 0 0 7,000
Payments on capital leases (587) (438) (232)
Treasury stock purchases (1,387) 0 0
Statutory tax withholding payment for share-based compensation (969) (438) 0
Proceeds from exercise of stock options 908 134 295
Payment of liabilities related to financing activities (100) (100) 0
Preferred stock dividends paid (61) 0 0
Net cash (used in) provided by financing activities (13,954) (105) 11,311
Effect of exchange rate changes on cash (34) 36 11
Net change in cash and cash equivalents 1,106 (2,116) 6,835
Cash and cash equivalents, beginning of period 5,537 7,653 818
Cash and cash equivalents, end of period 6,643 5,537 7,653
Supplemental disclosure of non-cash investing and financing activities:      
Accrued asset purchases 744 708 1,232
Accrued asset purchases 0 125 0
Property acquired under capital lease 211 1,588 0
Preferred stock dividends declared and not paid 60 0 0
Unrealized loss on investments (2) 0 0
Supplemental disclosure of cash flow information:      
Cash paid during the period for income taxes 89 104 60
Cash paid during the period for interest $ 1,077 $ 1,145 $ 1,029